- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
PSS World acquires more distributors
Medical supply and equipment distributor PSS World Medical of Jacksonville, FL, announced last month that its subsidiary, Diagnostic Imaging, has purchased three more distributors: Wallace X-Ray of Knoxville, TN; Western X-Ray of Salt Lake City; and
Medical supply and equipment distributor PSS World Medical of Jacksonville, FL, announced last month that its subsidiary, Diagnostic Imaging, has purchased three more distributors: Wallace X-Ray of Knoxville, TN; Western X-Ray of Salt Lake City; and Delta X-Ray of Oklahoma City. The three imaging companies represent combined revenues of $11 million and will be accounted for as cash purchase transactions.
On Jan. 5, the company reported that it had acquired Coastal Medical Systems of Seattle, a private imaging distributor that serves Washington, Oregon, Alaska, northern Idaho, and western Montana and boasts annual revenues of $9 million. The acquisitions bring PSS World Medical's distributor network to more than 61 sites nationwide.
FDA Approves Fluorescence Imaging System for Detecting Residual Breast Cancer
April 18th 2024The combination of the optical imaging agent Lumisight and the fluorescence imaging device Lumicell Direct Visualization System, collectively known as LumiSystem, reportedly offers 84 percent accuracy with real-time detection of residual breast cancer after lumpectomy procedures.
Study of Ofatumumab for Multiple Sclerosis Shows 'Profoundly Suppressed MRI Lesion Activity'
April 17th 2024The use of continuous ofatumumab in patients within three years of a relapsing multiple sclerosis diagnosis led to substantial reductions in associated lesions on brain MRI scans, according to research recently presented at the American Academy of Neurology (AAN) conference.
Could a Deep Learning Model for Mammography Improve Prediction of DCIS and Invasive Breast Cancer?
April 15th 2024Artificial intelligence (AI) assessment of mammography images may significantly enhance the prediction of invasive breast cancer and ductal carcinoma in situ (DCIS) in women with breast cancer, according to new research presented at the Society for Breast Imaging (SBI) conference.
